To include your compound in the COVID-19 Resource Center, submit it here.

Celltech licenses Pharmacia's Dipentum

Celltech (LSE:CCH; CLL) received an exclusive U.S. license from PHA to market and distribute Dipentum osalazine capsules to treat

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE